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Abstract We have cloned the mouse PA28 proteasome 
activator cDNAs. Northern blot demonstrates high PA28 mRNA 
levels in liver, kidney and lung. mRNA levels are low in thymus, 
spleen and brain. In contrast, PA28 protein levels vary little 
between these tissues. Immunocytological analysis and cell 
fractionation experiments demonstrate that both subunits are 
almost equally distributed between the cytoplasm and the 
nucleus. Interestingly, PA28oc spares nucleoli, while PA28P is 
strongly enhanced in the nucleolus. This indicates for the first 
time that the PA28a and PA28P subunits may serve nuclear 
functions which may be different from and independent of each 
other. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The 20S proteasome is the major cellular extra-lysosomal 
protease of eukaryotic cells [1]. This 700 kDa proteolytic com-
plex consists of 14 non-identical subunits ranging in molecular 
mass from 21 to 31 kDa [1]. The subunits can be classified as 
a and (3 type according to their homology to the a and (3 
subunits of the ancestral 20S proteasome of the archaebacte-
rium Thermoplasma acidophilum [2]. Three of the P subunits 
possess a free N-terminal threonine thought to be involved in 
the formation of the active sites which are oriented towards 
the lumen of the cylinder [3,4]. 
Being involved in such different processes such as cell 
division, antigen processing, transcription factor activation 
and protein turnover [5-7] proteasome activity can be modu-
lated through the interferon-y (IFN-y) induced exchange 
of specific P subunits or the interaction with regulatory pro-
teins. 
In the presence of ATP the 20S proteasome binds a 19S 
regulator complex (PA700) composed of about 15-20 different 
non-proteolytically active subunits to form the 26S protea-
some responsible for the ATP-ubiquitin-dependent pathway 
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of protein degradation [7]. PA700 which binds to the two a 
endplates of the 20S proteasome [8] appears to be responsible 
for the recognition of multi-ubiquitinated protein substrates 
via subunit S5a [9]. PA700 contains also subunits with AT-
Pase activities and subunits which cleave multi-ubiquitin 
chains during proteolysis [10]. 
In contrast to PA700, PA28 or US regulator associates 
with the 20S proteasome in an ATP-independent manner. 
PA28 stimulates the hydrolysis of small fluorogenic peptide 
substrates [11,12] and influences the processing of larger syn-
thetic polypeptide substrates in vitro [13]. The in vivo associ-
ation of PA28 and 20S proteasomes was demonstrated by 
Yang et al. [14]. The hexameric PA28 is formed by two 
non-identical subunits named PA28cc and PA28P. In SDS-
PAGE the subunits reveal an apparent molecular mass of 
31 kDa (a) and 29 kDa (P) respectively [15-17]. They form 
ring-shaped hexameric complexes with an approximate molec-
ular mass of 180 kDa [16,18] which bind to the a-endplates of 
the 20S proteasome [19,20]. A stoichiometry of three a and 
three P PA28 subunits per hexameric complex has recently 
been proposed [18,21,22]. As opposed to the 26S proteasome 
little is known about in vivo substrates of the PA28-20S pro-
teasome complex. The fact that PA28 a and P as well as the 
proteasome subunits LMP2, LMP7 and MECL-1 are up-regu-
lated by INF-y [16,23,6] suggested that PA28 participates in 
the cellular immune response. In support of this we recently 
were able to show that over-expression of PA28a enhances 
MHC-class I antigen presentation in mouse B8 fibroblast cells 
[24]. 
In the present communication we have analysed the 
mouse PA28. We cloned the PA28a and PA28P cDNAs 
and based on the deduced amino acid sequences we have 
raised subunit-specific antibodies. The subcellular distribution 
of PA28a, PA28P, and Ki autoantigen, the latter shares 
considerable sequence homology with the two activator 
subunits in mouse fibroblast B8 cells as well as the expression 
of the two PA28 subunits in different mouse tissues at the 
RNA and protein level was investigated. Our data show 
that mRNA levels of both PA28 subunits vary depending 
on the tissue analyzed. This variation is not reflected at 
protein level. PA28 subunits are present in the cytoplasm 
as well as in the nucleus while the Ki autoantigen, which 
exhibits extensive sequence identity with the PA28 subunits, 
is found exclusively in the nucleus. Interestingly, the nuclear 
staining patterns for PA28oc and PA28P are not identical and 
PA28P, in contrast to PA28a, seems to accumulate in the 
nucleolus. These data may indicate a so far unknown nu-
cleus-specific function for PA28P which is independent of 
PA28a. 
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2. Materials and methods 
2.1. Cloning of the PA28a and PA28p subunits of 
mouse PA28 regulator 
The mouse PA28a cDNA was isolated and cloned as previously 
described [24], The mouse cDNA encoding the PA28p subunits was 
isolated from a mouse spleen X-ZAP II phage library (C57 Black/6, 
Stratagene, Heidelberg). About 2X 106 recombinants were screened by 
plaque hybridization. A [a-32P]dATP-labelled PA28P rat cDNA [16] 
probe was used for hybridization. Hybridization conditions were as 
follows: hybridisation buffer was 6xNaCl/Cit. (lxNaCl/Cit. is 
0.15 M NaCl, 0.003 M sodium citrate, pH 7.0), 5XDenhardt, 
0.1% SDS, 10 mM EDTA, 100 ug/ml salmon DNA, 60°C overnight. 
The nitrocellulose filters were washed 2 times with 2xNaCl/Cit., 
0.1% SDS at room temperature for 20 min, and 2 times with 
0.2xNaCl/Cit, 0.1% SDS at 60°C for 20 min. The PA280 cDNA 
was excised by helper phage following the manufacturers' protocol. 
2.2. Antibody production 
Polyclonal mPA28a, mPA28(3 and human Ki antigen peptide anti-
bodies were raised by immunizing rabbits with KLH-coupled syn-
thetic peptides. For the mPA28a subunit residues 5-19 (RVHPEA-
QAKVDVFRE) and for the mPA28p subunit residues 16-31 
(KQVDVFRQNLFQEADDF) were used. For the human Ki-antigen 
[16] we used amino acid residues 70-86 (ILLTNSHDGLDGGPTYK). 
The polyclonal mPA28Prec antibody was generated from a PCR frag-
ment of 276 bp encoding amino acids 1 92. The PCR fragment was 
cloned into a pQE6xHis vector (Qiagen, Hilden, Germany). Cells 
were grown in LB (10 g bacto-tryptone, 5 g bacto yeast extract, 10 g 
NaCl) to an ODgoo of 0.8 and expression was stimulated by addition 
of isopropyl-p-D-thiogalactopyranoside (4 h, 37°C) to a final concen-
tration of 1 mM. The expressed recombinant protein was purified on 
a Ni-column purification system following the denaturing purification 
protocol described by Qiagen. Fractions (2 ml) were collected and 
analysed by SDS-PAGE. Purified recombinant protein was used for 
antibody production in rabbits. For immunofluorescence experiments 
all antibodies used were purified by affinity chromatography on anti-
gen coupled to epoxy-activated Sepharose 6B (Sigma) columns. 
2.3. Preparation of protein extract from mouse tissues and protein 
extracts from nuclei and cytoplasm of B8 cells 
Different mouse tissues were homogenized under liquid nitrogen. 
Homogenized tissue (100 mg) was lysed in 50 mM Tris-HCL (pH 
7.5), 5 mM MgCl2, 0.1% Triton-X 100, 1 mM EDTA; 6 mM aproti-
nin, 7 mM pepstatin, 1 mM PMSF; 10 mM leupeptin and homogen-
ized by using a teflon potter. After centrifugation at 20 000 X g at 4°C 
for 15 min. The supernatant was mixed with 4xSDS-sample buffer. 
Supernatant protein (60 |xg) was separated by conventional 15% SDS-
PAGE. Protein concentrations were determined as described by Brad-
ford [25]. Preparation of cytosolic and nuclear protein extracts from 
B8 cells was performed as described by [26]. 
2.4. Immunoblotting and electrophoretic methods 
Discontinuous tricine-SDS-PAGE system was carried out as de-
scribed [27]. Following SDS-PAGE gels were transferred onto nitro-
cellulose. Antigen-antibody complexes were detected by Western blot-
ting. For immuno-detection the BM Chemiluminescence kit from 
Boehringer Mannheim was used. 
2.5. RNA preparation and Northern blot 
Total RNA was isolated from mouse tissues using the RNA easy 
Kit from Qiagen. Separation on formaldehyde containing agarose 
gels, transfer onto membranes and radioactive probing were carried 
out as described previously [28]. 
2.6. Cell culture 
B8 fibroblast cells were grown in IMDM containing 10% fetal calf 
serum (FCS), 2 mM L-glutamine, 100 U/ml penicillin/streptomycin 
and 400 ug/ml G418 (Gibco). 
2.7. Immunofluorescence analysis of B8 cells 
Cells were fixed in 3.7% paraformaldehyde for 10 min, washed in 
quenching buffer (50 mM NH4CI in PBS) and permeabilized with 
0.1% NP-40 in washing buffer (PBS+0.01% saponine+0.25% gelatine) 
for 30 min at room temperature (RT). After incubation with the first 
antibody (mPA28ap 1:20; mPA28Pp 1:2 or hKi peptide antibody 
1:500) for 30 min at RT in a moist chamber, cells were washed 3 times 
for 10 min with washing buffer. The second fluorescein-conjugated 
antibody (goat anti-rabbit IgG, Jackson Immunoresearch Laborato-
ries, West Grove) was diluted 1:400 in FCS. The cells were incubated 
for 30 min at RT. Subsequent washing steps were performed as 
described before. Cells were embedded and placed onto a glass slide. 
For competition immunofluorescence assays affinity purified 
mPA28ap, and mPA28Pp antibodies were pre-incubated at 4°C over-
night with purified human PA28 at a molar ratio of 3:1. 
2.8. Double immunostaining 
Double immunostaining was performed essentially as described 
[29]. Fixed and permeabilized cells were washed and blocked with 
30% FCS for 15 min. Antibody incubations were performed for 
30 min in a humid chamber followed by three washing steps 10 min 
each. After incubation with the first PA28 antibody (rabbit anti-
mPA28ap) cells were incubated with fluorescein-conjugated Fab frag-
ment goat anti-rabbit IgG (H+L) (Jackson Immunoresearch Labora-
tories, diluted 1:300 in FCS). Subsequently PA28p was detected by 
the rabbit anti-mPA28Pp antibody which was stained by a Cy3-con-
jugated donkey anti-rabbit IgG (H+L) (Jackson Immunoresearch 
Laboratories, diluted 1:400). 
Microscopy was done with a Leica DMRXE microscope equipped 
with a 63 X plan apochromat objective. For photography Ilford XP2 
400 ASA film was used. 
3. Results 
3.1. Cloning and sequencing of mouse PA28a and PA28J5 
To allow the generation of subunit-specific antibodies di-
rected against the mouse proteasome activator PA28 a and P 
subunits and for the analysis of tissue-specific expression at 
both, the protein and mRNA level we isolated the corre-
sponding cDNAs from a mouse X.gtl 1 liver cDNA and a 
mouse AZAP-spleen cDNA library (see Section 2). The amino 
acid sequence deduced from the longest open reading frame of 
mPA28oc cDNA (Fig. 1A) corresponds to a protein of 249 
amino acids with a calculated molecular mass of 28 676 Da. 
Its sequence identity with the corresponding rat and human 
subunits is 95% and 91%, respectively (Fig. IB). 
The mPA28(J cDNA contains an open reading frame of 717 
nucleotides encoding a protein of 239 amino acids. The calcu-
lated molecular mass for the mouse P subunit is 27075 Da 
(Fig. 1A). The mouse PA28|3 protein is 94% and 87% identical 
to the corresponding rat and human subunits, respectively 
(Fig. 1C). The mPA28a and mPA28P proteins are 50% iden-
tical to one another (Fig. 1A). Interestingly, an alignment of 
murine PA28oc and PA28|3 shows a homogeneous distribution 
of homology throughout the protein except for a gap of 13 
amino acids in PA28|3. The region which is truncated in 
PA28p corresponds to the KEKE motif in PA28a which 
has been proposed to mediate protein-protein interaction of 
the 20S proteasome and the PA28 complex [30]. 
3.2. Analysis of mPA28a and mPA28fi mRNA and protein 
levels in different mouse tissues 
To determine the tissue specificity of mPA28cc and mPA28P 
gene expression, we examined the levels of PA28oc and PA28P 
mRNAs in different mouse tissues. Northern blot analysis 
shows that the mRNA levels of both subunits vary signifi-
cantly between the various mouse tissues (Fig. 2A,B). The 
mRNA levels for both subunits were related to the amount 
of P-actin mRNA on the same Northern blots (Fig. 2C). A 
densitometric analysis of the Northern blots revealed that the 
mRNA levels of both subunits are relatively high in liver, 
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Fig. 1. Deduced amino acid sequences of the mouse PA28 a and p subunits and sequence comparison. The protein sequences of the mouse 
PA28a and P subunits were deduced from the longest open reading frames of the corresponding mouse cDNAs. A: Comparison of PA28a and 
PA28P protein sequences from mouse; comparison of the PA28a (B) and PA28p (C) amino acid sequences from mouse rat and man. 
kidney and lung while thymus and spleen contain significantly 
less PA28oc and PA28|3 mRNA. Interestingly, only negligible 
levels of PA28oc and PA28|3 mRNA are found in brain (Fig. 
2D). 
Since mRNAs as well as the corresponding protein prod-
ucts can be controlled at post-transcriptional or post-transla-
tional level low amounts of mRNA do not necessarily reflect 
low levels of the corresponding proteins. Therefore, we sepa-
rately determined PA28oc and P protein quantities in various 
mouse tissues. To differentiate between the PA28a and PA28|3 
subunits we raised subunit-specific polyclonal antibodies. A 
synthetic peptide covering amino acid residues 5-19 was 
used for the production of PA28a-specific antibodies 
(mPA28ocp) and a PA28|3-speciflc antibody (mPA28|3rec) 
was obtained with a recombinant protein representing the 
N-terminal part of the protein (see Section 2). The subunit 
specificity of the antibodies was tested and documented by 
ECL immunoblotting (Fig. 3D). In agreement with the calcu-
lated molecular mass of 28.6 kDa for the a and 27 kDa for 
the p subunit and in contrast to recently reported data [21] 
our analysis of PA28a and PA28p protein migration in tri-
cine-SDS-PAGE demonstrate that the upper of the two acti-
vator proteins is recognized by the antibody mPA28ocp and 
that mPA28Prec identifies only the faster migrating protein 
which consequently represents the PA28P subunit. 
Equal amounts of total protein from different mouse tissues 
were loaded in each lane, separated by SDS-PAGE and trans-
ferred onto nitrocellulose membranes. As shown in Fig. 3A,B, 
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Fig. 2. Analysis of PA28cc and P mRNA levels in different mouse tissues by Northern blot analysis. 15 (ig of total RNA of different mouse tis-
sues were loaded onto each lane. The mPA28a and mPA28P mRNA accumulation was detected using [a-32P]dATP-labelled cDNA fragments 
of mPA28a (A) and mPA28p (B), respectively. A P-actin cDNA fragment was used as a control (C). Densitometric analysis of the Northern 
blots and adjustment of the values to the P-actin standard (D). 
subunits PA28a as well as PA28(J are expressed in all exam-
ined tissues. However, in contrast to the differences in mRNA 
accumulation in these tissues PA28a and PA28p protein levels 
do not significantly vary. Interestingly, when compared with 
the other tissues, thymus and spleen possess even increased 
amounts of PA28 protein in spite of a low PA28oc and PA28|3 
mRNA expression. 
In conventional SDS-PAGE both, PA28oc and PA28|3, mi-
grate at a position of 30 kDa in most murine tissues (Fig. 
3A,B). A surprising exception was noted when Western blots 
were probed with the PA28P-specific antibody: in murine 
brain only a faint band was detected at 30 kDa when com-
pared to other tissues and instead a prominent band appeared 
at 33 kDa. This finding was highly reproducible even when 
affinity purified mPA28prec was used. Moreover, a brain-spe-
cific 33 kDa protein was also detected with a polyclonal PA28 
antibody raised against purified human PA28 [17] (designated 
'hPA28') but not with our PA28oc-specific reagent. A fortui-
tous cross-reactivity with an unrelated brain-specific protein is 
therefore unlikely. Rather our results suggest that PA28P ex-
ists in a strongly modified form or that a tissue-specific larger 
isoform of PA28p is expressed in the murine brain. Covalent 
modification of PA28P with phosphate or charged sugars, 
however, are unlikely to account for the observed increase 
in molecular mass as we did not detect a charge difference 
in PA28P from mouse liver and brain in Western blots of 
two-dimensional IEF/SDS-PAGE (data not shown). 
Further bands of about 45 kDa were detected by the 
mPA28ap antibody in brain and by the mPA28prec antibody 
in kidney, but as these bands were not detected with the PA28 
polyclonal antibody, we cannot be certain whether the de-
tected proteins are related to PA28 subunits or whether they 
are cross-reacting organ specific proteins. 
3.3. PA28a and PA28/5 subunits are localized in the cytoplasm 
as well as in the nucleus 
To analyze the subcellular distribution of PA28a and 
PA28p subunits in mouse fibroblast B8 cells, we used affinity 
purified antibodies for indirect immunofluorescence micros-
copy (Fig. 4) and for Western analysis of cytoplasmic and 
nuclear fractions (Fig. 3E). The specificity of the applied anti-
body preparations was confirmed by competition experiments 
in immunofluorescence microscopy as a pre-incubation of the 
mPA28ocp and mPA28Prec antibodies with purified PA28 
complexes reduced the fluorescence signal almost to back-
ground levels (not shown). Immunostaining of mouse B8 cells 
demonstrates that both PA28 subunits are evenly distributed 
between the cytoplasm and the nucleus of the fibroblast cells. 
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Fig. 3. Western blot analysis of PA28a and P protein subunit iden-
tity and protein levels in different mouse tissues. A: Immunoblot 
analysis of PA28a. B: Immunoblot analysis of PA28|3. 60 ug of 
protein extract from different mouse tissues were loaded onto each 
lane. For immunoblotting the antibodies mPA28ccp and mPA28(3rec 
were used. C: Coomassie-stained blot of purified human PA28 
(1.5 ug/lane) after separation on a discontinuous tricine-SDS-PAGE 
prepared according to Schagger and von Jagow [27]. D: Assignment 
of PA28cc and PA28P subunits on purified and immunoblotted hu-
man PA28. The Western blots shown in (D) were probed with anti-
bodies mPA28ap (right) and mPA28Prec (left). E: Identification of 
mouse PA28 subunits in nuclear and cytoplasmic extracts of mouse 
B8 fibroblast cells. 30 ug of protein from the crude cytoplasmic (C) 
and crude nuclear (N) fraction of B8 cells were separated on 15% 
SDS PAGE. PA28 subunits were identified by immunoblotting with 
affinity purified antibodies mPA28ap (1C, 2N), mPA28Prec (3C, 
4N) and mPA28pP (5C, 6N). 
PA28oc staining reveals a slight accumulation of the antigen in 
the nucleus where a speckled immunofluorescence image is 
observed. The nucleoli of the fibroblast cells are still visible 
as only weakly stained hollows (Fig. 4A). In contrast to the a 
subunit, PA28(3 immunostaining reveals particulate nuclear 
immunofluorescence signals (Fig. 4B). The distribution of 
PA28P fluorescence is consistent with an accumulation of 
PA28P in nucleoli. When mouse glia cells were analysed an 
identical fluorescence pattern was observed demonstrating 
that this result is not peculiar to mouse fibroblast cells (Stoh-
wasser, personal communication). 
In order to compare the intracellular distribution of the 
homologous Ki autoantigen to that of PA28a and PA28p 
we raised polyclonal antibodies in rabbits against a synthetic 
peptide corresponding to a region in the Ki sequence which 
lacks homology to PA28ot and PA28p. Fig. 4C shows that Ki 
fluorescence is found exclusively in the nucleus leaving the 
presumed nucleoli as unstained hollows while the cytoplasm 
was completely devoid of Ki fluorescence. This result is in 
agreement with the existence of a nuclear targeting site in 
the Ki sequence which resembles that of the SV40 large T 
protein [31] and with the initial description of Ki as a nuclear 
antigen [32]. It also demonstrates that the affinity purified Ki 
antibody does not cross-react with PA28cx or PA28P. 
Taken together we conclude from these experiments that 
PA28 subunits are present in the cytosol as well as in the 
nucleus and that in contrast to existing biochemical evidence 
the PA28 subunits PA28a and PA28p do not always co-local-
ize in the nuclear compartment. Furthermore, these data sug-
gest that in addition to modulating the 20S proteasome activ-
ity the two PA28 subunits may possess mutually independent 
functions. 
The observation, that PA28 antigens are predominant in 
nuclei was surprising. Nevertheless, the immuncytological 
data are compatible with immunoblotting experiments in 
which cytosolic and nuclear extracts of B8 cells were screened 
with PA28 antibodies (Fig. 3E). These experiments reveal that 
the PA28oc subunit is present in the nuclear and cytosolic 
fractions at approximately equal amounts while the PA28p 
subunits is even slightly enriched in the nuclear fraction. 
4. Discussion 
In the present study we cloned the cDNAs encoding the two 
mouse proteasome activator PA28 subunits and analysed the 
PA28 mRNA as well as protein expression levels in different 
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Fig. 4. Subcellular distribution of mPA28a and mPA28B protein subunits and the Ki autoantigen by fluorescence microscopy of mouse fibro-
blast B8 cells. For immunodetection of mPA28a and mPA28B paraformaldehyde-fixed B8 cell were used for indirect immunofluorescence. 
A: Immunodetection of the PA28cc subunit with affinity purified mPA28oc peptide antibody. B: Immunodetection of the PA28B subunit with 
affinity purified mPA28B peptide antibodies. C: Immunodetection of the Ki antigen with affinity purified antibodies. Pictures E, F, G represent 
phase contrast images of A, B, C. Lower panel shows double immunostaining of PA28a and B. D: PA28a; H: PA28B. 
mouse tissues. In addition, we show for the first time the 
intracellular distribution of both the a and p subunits by 
immunofluorescence microscopy. 
The primary structures of the mouse PA28oc and PA28J3 
subunits are 50% identical to each other whereas the 
mPA28 a subunit is 97% (93%) and the mPA28(3 subunit 
93% (87%) identical to the corresponding rat and human ac-
tivator proteins [16,33]. These high sequence identities support 
the suggestion [16] that the a and (3 type PA28 genes originate 
from a common ancestor. 
Both subunits of the proteasome activator PA28 as well as 
the non-constitutive proteasome (3-subunits LMP2, LMP7 
and MECL-1 are up-regulated by INF-y. Following induc-
tion, the three proteasome p subunits which modulate the 
proteolytic activities of the enzyme complex replace their con-
stitutive homologues forming proteasome complexes which 
appear to be more appropriate for the processing of endoge-
nous antigens presented by MHC class I molecules [6,34]. The 
mRNA levels of the non-inducible proteasome subunits were 
shown to be more or less constant in different tissues [1]. This 
differs to the IFN-y-inducible subunits LMP2, LMP7 and 
MECL-1 whose constitutive steady-state mRNA levels were 
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shown to vary strongly between different mouse tissues 
[35,36]. In particular thymus and spleen, two tissues which 
are tightly connected with the immune response, exhibit 
high constitutive levels of LMP and MECL-1 mRNAs. In 
complete contrast, mRNA levels of mPA28rx and mPA28(3 
appear to be particularly low in thymus and spleen. Even 
lower amounts of PA28 mRNA are only found in brain. 
This striking difference in the constitutive levels between the 
two groups of mRNA may indicate that IFN-y-inducible pro-
teasome P-subunits and factors enhancing proteasome activity 
underlie, in the absence of the cytokine, different transcrip-
tional regulatory mechanisms. Alternatively, there exists also 
the possibility that in different tissues the two groups of 
mRNAs possess different half-lives and that PA28 mRNAs 
are relatively short lived in these tissues. 
In a recent publication there has been some confusion with 
regard to which of the two PA28 proteins represent the a and 
p subunits [21]. Our immunoblotting experiments provide 
clear evidence that in accordance with the deduced molecular 
mass and in agreement with data of Kuhn and Dahlmann [17] 
the upper protein band represent the a and the faster migrat-
ing protein the (3 subunit of PA28. 
Interestingly, our Western blot analysis of PA28 protein 
levels in the different tissues shows that in comparison to 
the low mRNA levels large amounts of the corresponding 
mPA28oc and mPA28|3 proteins are detected in brain, spleen 
and thymus. Thus it appears that the low amounts of PA28 
mRNAs are compensated either by increased protein stability 
or by translation efficiency. It is notable that despite the var-
iations in PA28 mRNAs the relative PA28 protein levels are 
very similar in the various tissues. Only in thymus and spleen 
the amount PA28oc and P protein is somewhat higher than in 
the other tissues analyzed here. 
Our experiments also show that in brain the PA28|3 subunit 
exhibits a slightly lower electrophoretic mobility than that of 
the other tissues and that no protein corresponding to the 
electrophoretic mobility was found for this subunit in the 
other tissues could be detected. The PA28(3 subunits of retic-
ulocytes as well as human erythrocytes were recently shown to 
be phosphorylated [37] but a brain-specific hyper-phosphoryl-
ation of PA28|3 appears to be unlikely as we did not observe a 
shift towards a negative charge in the larger PA28(3 protein 
from murine brain. Alternatively the difference in molecular 
mass of PA28p may reflect the existence of a tissue-specific 
isoform of the P subunit. The presence of distinct tissue-spe-
cific isoforms for proteins of the proteasome system was re-
cently documented in Drosophila [38]. The latter possibilities 
are currently under investigation in our laboratory. Addition-
al proteins with an apparent molecular mass of 45 and 55 kDa 
were detected before in all examined tissues [39]. In our blot-
ting experiments we also detected proteins of approximately 
45 kDa in extracts of kidney and brain. However, since these 
proteins were not detected with antibody hPA28 we regard 
these signals as unrelated to the PA28. 
For a number of mammalian tissues, cultures of vertebrate 
cells and invertebrates 20S proteasome complexes were shown 
to be localized in the cytoplasm as well as in the nucleus [1]. 
In fact, dependent on the metabolic state of certain tissues or 
cell types the subcellular distribution of proteasome com-
plexes appears to be differently regulated [40,41]. Strong nu-
clear localization of proteasomes was observed in rapidly di-
viding cells [40] and Peters and coworkers [42] showed that the 
nuclear immunofluorescence of 26S proteasome was more in-
tense than in the cytoplasm. Only nucleoli and metaphase 
chromosome remained unstained. Our analysis of the subcel-
lular distribution of PA28 in mouse fibroblast cells reveals 
that the activator subunits are distributed almost equally be-
tween the nucleus and the cytoplasm a result which is also 
supported by cell fractionation experiments. Similar results 
were obtained for mouse microglia (Stohwasser, personal 
communication) excluding the possibility that this represents 
a peculiarity of B8 cells. As judged from the immunofluores-
cence and immunoblotting experiments performed here, which 
reflect the steady-state situation in fibroblast cells, the amount 
of PA28 proteins present in the nucleus is considerably higher 
than the 10% reported by Ahn et al. [21] which immunopre-
cipitated PA28 from subfractions of pulse-labelled Hela cells. 
Our results also reveal that the a and p subunits of PA28 
do not completely co-localize in the nucleus and that they are 
present in different nuclear substructures. The P subunit is 
shown to strongly accumulate in the nucleoli whereas the a 
subunit does not accumulate in these sites and rather occupies 
the nucleoplasm. Although immunocytological data always 
should be interpreted with care these experiments indicate 
for the first time that the a and p subunits of PA28 may exists 
independent from each other and that they may serve different 
functions in the nucleus. Whether both subunits can interact 
with other proteins in vivo is at present unknown. For the 
rx-subunit it has been shown that the recombinant subunit is 
able to activate proteasomal peptide hydrolyzing activity and 
to form complexes in vitro [30]. However, there is no evidence 
that such complexes are also formed in vivo [21]. Further-
more, in vitro the P-subunit on its own is not able to activate 
the hydrolyzing activity of the 20S proteasome complex [18]. 
Thus it appears that both proteins may require other partners 
to exert their in vivo function. Whether both proteins, besides 
forming PA28 complexes with each other, possess indeed ad-
ditional protein partners in the nucleus or nucleolus must be a 
subject of further investigations. 
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